<< Back To HomeNeonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Printable Copy |
|
Vaccine. 2016 Jul 19. pii: S0264-410X(16)30023-8. doi: 10.1016/j.vaccine.2016.03.040. [Epub ahead of print]
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
Pathirana J1, Muñoz FM2, Abbing-Karahagopian V3, Bhat N4, Harris T5, Kapoor A6, Keene DL7, Mangili A8, Padula MA9, Pande SL10, Pool V11, Pourmalek F12, Varricchio F13, Kochhar S14, Cutland CL15; Brighton Collaboration Neonatal Death Working Group.
Author information
- 1Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- 2Departments of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
- 3Global Clinical Research & Development - Epidemiology Novartis/GSK Vaccines, Amsterdam, The Netherlands.
- 4Program for Appropriate Technology in Health (PATH), Seattle, USA.
- 5Immunization and Vaccine Preventable Diseases, Public Health Ontario, Canada.
- 6Immunization Technical Support Unit - Ministry of Health and Family Welfare, Public Health Foundation of India, New Delhi, India.
- 7Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ontario, Canada.
- 8Tufts University School of Medicine, Boston, MA, USA.
- 9Division of Neonatology, The Childrens Hospital of Philadelphia and University of Pennsylvania, USA.
- 10Ministry of Health Uganda, Soroti Regional Referral Hospital, Uganda.
- 11Sanofi Pasteur Inc., Swiftwater, PA, USA.
- 12School of Population and Public Health, University of British Columbia, Vancouver, Canada.
- 13Independent Consultant, Vaccinologist, USA.
- 14Global Healthcare Consulting, New Delhi, India.
- 15Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: contact@brightoncollaboration.org.
Abstract below; full text is at http://www.sciencedirect.com/science/article/pii/S0264410X16300238
More than 40% of all deaths in children under 5 years of age occur during the neonatal period: the first month of life. Immunization of pregnant women has proven beneficial to both mother and infant by decreasing morbidity and mortality. With an increasing number of immunization trials being conducted in pregnant women, as well as roll-out of recommended vaccines to pregnant women, there is a need to clarify details of a neonatal death. This manuscript defines levels of certainty of a neonatal death, related to the viability of the neonate, who confirmed the death, and the timing of the death during the neonatal period and in relation to immunization of the mother.
Copyright © 2016. Published by Elsevier Ltd.
Similar articles